Transgenomic Announces Medicare Coverage for Clopidogrel (Plavix®) Response Test
July 24, 2012
OMAHA, Neb. (July 24, 2012) – Transgenomic, Inc. (OTC/BB: TBIO) today announced that National Government Services, the designated Medicare fiscal intermediary in Connecticut, has confirmed coverage for its proprietary Clopidogrel Genetic Absorption Activation Panel (C-GAAP, formerly PGxPREDICT®:Clopidogrel). As a result of this coverage, the 48 million Americans currently covered by Medicare will have access to [...]
Portable device detects soil contamination
July 24, 2012
The RemScan™ device uses an infrared signal to directly measure petroleum hydrocarbons in soil. The user simply pulls the trigger for a result in 15 seconds. The traditional method for measuring petroleum contamination involves sending soil samples to a laboratory and waiting several days for the results. Petroleum contamination is a wide spread global issue [...]
Life Technologies and SATuRN Collaborate to Increase Access to HIV Testing in Africa
July 24, 2012
CARLSBAD, Calif., -- Life Technologies Corporation (NASDAQ: LIFE ) today announced a collaboration with the Southern African Treatment and Resistance Network (SATuRN — https://www.bioafrica.net/saturn) on sequencing-based diagnostics for HIV-infected individuals in Africa. Antiretroviral (ARV) drugs are becoming increasingly available in the developing world, due to facilitation by both governmental and non-governmental organizations, as well as [...]
FEI Announces New Titan ETEM G2: Imaging Dynamic Processes at the Atomic Scale
July 24, 2012
Hillsboro, Ore ? FEI (NASDAQ: FEIC), a leading instrumentation company providing imaging and analysis systems for research and industry, today announced the release of the new Titan™ ETEM G2?an environmental transmission electron microscope (ETEM) that enables time-resolved, in-situ studies of processes and materials exposed to reactive gases and elevated temperatures. Developers of energy and environmental [...]
Gen-Probe and Life Technologies to Co-Distribute SeCore® HLA Sequence-Based Typing Products
July 24, 2012
SAN DIEGO and CARLSBAD, Calif., -- Gen-Probe Incorporated (NASDAQ: GPRO) and Life Technologies Corporation (NASDAQ: LIFE) today announced they have signed a distribution agreement for SeCore® HLA Sequence-Based Typing (SBT) kits for use with Life Technologies' 3500 Dx Genetic Analyzer. Under the terms of the agreement, Gen-Probe's LIFECODES unit will have co-exclusive rights to sell [...]
July 24, 2012
PresseBox) Berlin, - JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the use of their NanoWizard® AFM systems at the Microscopy & Imaging Facility (MIF) at the University of Calgary in Canada. The Calgary Microscopy and Imaging Facility (MIF) is a world-class university-wide facility housing [...]
Stringent Paperless Process Documentation for Media Preparation Labs
July 24, 2012
INTEGRA has announced that its MEDIACLAVE 10/30 media preparation systems have been upgraded to provide all the necessary tools to support the most stringent process documentation and validation needs. More and more laboratories rely on electronic process documentation to avoid costs associated with paper use and excessive storage space requirements. However, laboratories must also ensure [...]
SwitchGear Genomics Expands LightSwitch Luciferase Assay System™ by Adding Custom Cloning Services
July 24, 2012
SwitchGear Genomics Inc., a leading provider of products for studying the regulatory elements in the human genome, today announced the launch of a new service group for custom cloning and mutagenesis. These services will provide customers new ways to access the LightSwitch Luciferase Assay System™, a comprehensive reporter assay platform for studying transcriptional and post-transcriptional [...]
July 24, 2012
Franklin Lakes, NJ – The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX) has declared a quarterly dividend of 45 cents per common share, payable on September 28, 2012 to holders of record on September 7, 2012. The indicated annual dividend rate is $1.80 per share. About BD BD is a leading global [...]
Vitro Biopharma Strengthens and Expands Its Distribution Agreement With Neuromics
July 24, 2012
Golden, Colorado —— Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced an expanded relationship with a key distributor of its stem cell-based products, privately-held Neuromics, Inc (www.neuromics.com). Vitro Biopharma officials recently met Neuromics principals at their corporate headquarters in Minneapolis, MN. Neuromics was formed in 2005 by Pete Shuster, a marketing and sales professional [...]

